{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:38:13Z","timestamp":1787002693171,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T00:00:00Z","timestamp":1574380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/S005528\/1"],"award-info":[{"award-number":["MR\/S005528\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N025377\/1"],"award-info":[{"award-number":["MR\/N025377\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/N026063\/1"],"award-info":[{"award-number":["MR\/N026063\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","award":["CM234"],"award-info":[{"award-number":["CM234"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002283","name":"Alzheimer's Research UK","doi-asserted-by":"publisher","award":["ARUK-RF2016A-1"],"award-info":[{"award-number":["ARUK-RF2016A-1"]}],"id":[{"id":"10.13039\/501100002283","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Parkinson\u2019s disease (PD) is an \u03b1-synucleinopathy characterized by the progressive loss of specific neuronal populations. Here, we develop a novel approach to transvascularly deliver proteins of complex quaternary structures, including \u03b1-synuclein preformed fibrils (pff). We show that a single systemic administration of \u03b1-synuclein pff triggers pathological transformation of endogenous \u03b1-synuclein in non-transgenic rats, which leads to neurodegeneration in discrete brain regions. Specifically, pff-exposed animals displayed a progressive deterioration in gastrointestinal and olfactory functions, which corresponded with the presence of cellular pathology in the central and enteric nervous systems. The \u03b1-synuclein pathology generated was both time dependent and region specific. Interestingly, the most significant neuropathological changes were observed in those brain regions affected in the early stages of PD. Our data therefore demonstrate for the first time that a single, transvascular administration of \u03b1-synuclein pff can lead to selective regional neuropathology resembling the premotor stage of idiopathic PD. Furthermore, this novel delivery approach could also be used to deliver a range of other pathogenic, as well as therapeutic, protein cargos transvascularly to the brain.<\/jats:p>","DOI":"10.1038\/s41380-019-0608-9","type":"journal-article","created":{"date-parts":[[2019,11,22]],"date-time":"2019-11-22T09:03:09Z","timestamp":1574413389000},"page":"556-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Systemic \u03b1-synuclein injection triggers selective neuronal pathology as seen in patients with Parkinson\u2019s disease"],"prefix":"10.1038","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-1320","authenticated-orcid":false,"given":"Wei-Li","family":"Kuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4014-1188","authenticated-orcid":false,"given":"Katherine","family":"Stott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias C.","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujeong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9798-9083","authenticated-orcid":false,"given":"Jessica C. F.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Tietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin I.","family":"Aigbirhio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7305-1069","authenticated-orcid":false,"given":"Anthony C.","family":"Vernon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger A.","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,22]]},"reference":[{"key":"608_CR1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M. Alpha-synuclein in Lewy bodies. Nature. 1997;388:839\u201340.","journal-title":"Nature."},{"key":"608_CR2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nm1747","volume":"14","author":"JH Kordower","year":"2008","unstructured":"Kordower JH, Chu Y, Hauser RA, Freeman T, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson\u2019s disease. Nat Med. 2008;14:504\u20137.","journal-title":"Nat Med."},{"key":"608_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nm1746","volume":"14","author":"JY Li","year":"2008","unstructured":"Li JY, Englund E, Holton JL, Soulet D, Hagell P, Lees AJ, et al. Lewy bodies in grafted neurons in subjects with Parkinson\u2019s disease suggest host-to-graft disease propagation. Nat Med. 2008;14:501\u20133.","journal-title":"Nat Med."},{"key":"608_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-002-1301-4","volume":"249","author":"H Braak","year":"2002","unstructured":"Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, R\u00fcb U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease. J Neurol. 2002;249:1\u20135.","journal-title":"J Neurol."},{"key":"608_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24:197\u2013211.","journal-title":"Neurobiol Aging."},{"key":"608_CR6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk KC, Kehm V, Carroll J, Zhang B, O\u2019Brien P, Trojanowski JQ, et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in non-transgenic mice. Science. 2012;338:949\u201353.","journal-title":"Science."},{"key":"608_CR7","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1016\/j.celrep.2016.08.053","volume":"16","author":"KC Luk","year":"2016","unstructured":"Luk KC, Covell DJ, Kehm VM, Zhang B, Song IY, Byrne MD, et al. Molecular and biological compatibility with host alpha-synuclein influences fibril pathogenicity. Cell Rep. 2016;16:3373\u201387.","journal-title":"Cell Rep."},{"key":"608_CR8","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey NL, Steiner JA, Maroof N, Luk KC, Madaj Z, Trojanowski JQ, et al. Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J Exp Med. 2016;213:1759\u201378.","journal-title":"J Exp Med"},{"key":"608_CR9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-017-0413-0","volume":"5","author":"A Shimozawa","year":"2017","unstructured":"Shimozawa A, Ono M, Takahara D, Tarutani A, Imura S, Masuda-Suzukake M, et al. Propagation of pathological \u03b1-synuclein in marmoset brain. Acta Neuropathol Commun. 2017;5:12.","journal-title":"Acta Neuropathol Commun."},{"key":"608_CR10","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00401-014-1343-6","volume":"128","author":"S Holmqvist","year":"2014","unstructured":"Holmqvist S, Chutna O, Bousset L, Aldrin-Kirk P, Li W, Bj\u00f6rklund T, et al. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol. 2014;128:805\u201320.","journal-title":"Acta Neuropathol."},{"key":"608_CR11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts W, Bousset L, Van der Perren A, Moskalyuk A, Pulizzi R, Giugliano M, et al. \u03b1-synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature. 2015;522:340\u20134.","journal-title":"Nature."},{"key":"608_CR12","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.expneurol.2016.09.003","volume":"285","author":"WL Kuan","year":"2016","unstructured":"Kuan WL, Bennett N, He X, Skepper JN, Martynyuk N, Wijeyekoon R, et al. \u03b1-synuclein pre-formed fibrils impair tight junction protein expression without affecting cerebral endothelial cell function. Exp Neurol. 2016;285:72\u201381.","journal-title":"Exp Neurol."},{"key":"608_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nature05901","volume":"448","author":"P Kumar","year":"2007","unstructured":"Kumar P, Wu H, McBride JL, Jung KE, Kim MH, Davidson BL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature. 2007;448:39\u201343.","journal-title":"Nature."},{"key":"608_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.20111126","volume":"209","author":"WL Kuan","year":"2012","unstructured":"Kuan WL, Poole E, Fletcher M, Karniely S, Tyers P, Wills M, et al. A novel neuroprotective therapy for Parkinson\u2019s disease using a viral noncoding RNA that protects mitochondrial complex I activity. J Exp Med. 2012;209:1\u201310.","journal-title":"J Exp Med"},{"key":"608_CR15","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.chembiol.2014.11.009","volume":"22","author":"S Zeller","year":"2015","unstructured":"Zeller S, Choi CS, Uchil PD, Ban HS, Siefert A, Fahmy TM, et al. Attachment of cell-binding ligands to arginine-rich cell-penetrating peptides enables cytosolic translocation of complexed siRNA. Chem Biol. 2015;22:50\u201362.","journal-title":"Chem Biol."},{"key":"608_CR16","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.neuron.2013.12.033","volume":"81","author":"N Zampieri","year":"2014","unstructured":"Zampieri N, Jessell TM, Murray AJ. Mapping sensory circuits by anterograde trans-synaptic transfer of recombinant rabies virus. Neuron. 2014;81:766\u201378.","journal-title":"Neuron."},{"key":"608_CR17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1523\/JNEUROSCI.2283-12.2013","volume":"33","author":"V Vorobyov","year":"2013","unstructured":"Vorobyov V, Kwok JC, Fawcett JW, Sengpiel F. Effects of digesting chondroitin sulfate proteoglycans on plasticity in cat primary visual cortex. J Neurosci. 2013;33:234\u201343.","journal-title":"J Neurosci."},{"key":"608_CR18","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1021\/bi901723p","volume":"49","author":"CR Bodner","year":"2010","unstructured":"Bodner CR, Maltsev AS, Dobson CM, Bax A. Differential phospholipid binding of alpha-synuclein variants implicated in Parkinson\u2019s disease revealed by solution NMR spectroscopy. Biochemistry. 2010;49:862\u201371.","journal-title":"Biochemistry."},{"key":"608_CR19","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nsmb.3194","volume":"23","author":"MD Tuttle","year":"2016","unstructured":"Tuttle MD, Comellas G, Nieuwkoop AJ, Covell DJ, Berthold DA, Kloepper KD, et al. Solid-state NMR structure of a pathogenic fibril of full-length human \u03b1-synuclein. Nat Struct Mol Biol. 2016;23:409\u201315.","journal-title":"Nat Struct Mol Biol"},{"key":"608_CR20","doi-asserted-by":"crossref","first-page":"765","DOI":"10.3233\/JPD-150670","volume":"5","author":"C Preterre","year":"2015","unstructured":"Preterre C, Corbill\u00e9 AG, Balloy G, Letournel F, Neunlist M, Derkinderen P. Optimizing western blots for the detection of endogenous \u03b1-synuclein in the enteric nervous system. J Parkinsons Dis. 2015;5:765\u201372.","journal-title":"J Parkinsons Dis"},{"key":"608_CR21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/cb900112v","volume":"4","author":"A Aslund","year":"2009","unstructured":"Aslund A, Sigurdson CJ, Klingstedt T, Grathwohl S, Bolmont T, Dickstein DL, et al. Novel pentameric thiophene derivatives for in vitro and in vivo optical imaging of a plethora of protein aggregates in cerebral amyloidoses. ACS Chem Biol. 2009;4:673\u201384.","journal-title":"ACS Chem Biol"},{"key":"608_CR22","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1002\/mds.23305","volume":"25","author":"AE Kingsbury","year":"2010","unstructured":"Kingsbury AE, Bandopadhyay R, Silveira-Moriyama L, Ayling H, Kallis C, Sterlacci W, et al. Brain stem pathology in Parkinson\u2019s disease: an evaluation of the Braak staging model. Mov Disord. 2010;25:2508\u201315.","journal-title":"Mov Disord"},{"key":"608_CR23","volume":"5","author":"A Sasaki","year":"2015","unstructured":"Sasaki A, Arawaka S, Sato H, Kato T. Sensitive western blotting for detection of endogenous Ser129-phosphorylated \u03b1-synuclein in intracellular and extracellular spaces. Sci Rep. 2015;5:14211.","journal-title":"Sci Rep."},{"key":"608_CR24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1750-1326-7-42","volume":"7","author":"KM Danzer","year":"2012","unstructured":"Danzer KM, Kranich LR, Ruf WP, Cagsal-Getkin O, Winslow AR, Zhu L, et al. Exosomal cell-to-cell transmission of alpha synuclein oligomers. Mol Neurodegener. 2012;7:42.","journal-title":"Mol Neurodegener"},{"key":"608_CR25","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/ana.23747","volume":"72","author":"EC Freundt","year":"2012","unstructured":"Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, et al. Neuron-to-neuron transmission of \u03b1-synuclein fibrils through axonal transport. Ann Neurol. 2012;72:517\u201324.","journal-title":"Ann Neurol."},{"key":"608_CR26","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.15252\/embj.201593411","volume":"35","author":"S Abounit","year":"2016","unstructured":"Abounit S, Bousset L, Loria F, Zhu S, de Chaumont F, Pieri L, et al. Tunneling nanotubes spread fibrillar \u03b1-synuclein by intercellular trafficking of lysosomes. EMBO J. 2016;35:2120\u201338.","journal-title":"EMBO J."},{"key":"608_CR27","doi-asserted-by":"crossref","first-page":"aah3374","DOI":"10.1126\/science.aah3374","volume":"353","author":"X Mao","year":"2016","unstructured":"Mao X, Ou MT, Karuppagounder SS, Kam TI, Yin X, Xiong Y, et al. Pathological \u03b1-synuclein transmission initiated by binding lymphocyte-activation gene 3. Science. 2016;353:aah3374.","journal-title":"Science."},{"key":"608_CR28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrn.2016.13","volume":"17","author":"DM Walsh","year":"2016","unstructured":"Walsh DM, Selkoe DJ. A critical appraisal of the pathogenic protein spread hypothesis of neurodegeneration. Nat Rev Neurosci. 2016;17:251\u201360.","journal-title":"Nat Rev Neurosci"},{"key":"608_CR29","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.neuron.2010.04.034","volume":"66","author":"TM Dawson","year":"2010","unstructured":"Dawson TM, Ko HS, Dawson VL. Genetic animal models of Parkinson\u2019s disease. Neuron. 2010;66:646\u201361.","journal-title":"Neuron."},{"key":"608_CR30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.24648","volume":"79","author":"MG Stokholm","year":"2016","unstructured":"Stokholm MG, Danielsen EH, Hamilton-Dutoit SJ, Borghammer P. Pathological \u03b1-synuclein in gastrointestinal tissues from prodromal Parkinson disease patients. Ann Neurol. 2016;79:940\u20139.","journal-title":"Ann Neurol."},{"key":"608_CR31","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2019.05.035","volume":"103","author":"S Kim","year":"2019","unstructured":"Kim S, Kwon SH, Kam TI, Panicker N, Karuppagounder SS, Lee S, et al. Transneuronal propagation of pathologic \u03b1-synuclein from the gut to the brain models Parkinson\u2019s disease. Neuron. 2019;103:627\u201341.","journal-title":"Neuron."},{"key":"608_CR32","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.nbd.2018.01.008","volume":"112","author":"FP Manfredsson","year":"2018","unstructured":"Manfredsson FP, Luk KC, Benskey MJ, Gezer A, Garcia J, Kuhn NC, et al. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology. Neurobiol Dis. 2018;112:106\u201318.","journal-title":"Neurobiol Dis."},{"key":"608_CR33","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13024-018-0257-5","volume":"13","author":"N Uemura","year":"2018","unstructured":"Uemura N, Yagi H, Uemura MT, Hatanaka Y, Yamakado H, Takahashi R. Inoculation of \u03b1-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve. Mol Neurodegener. 2018;13:21.","journal-title":"Mol Neurodegener."},{"key":"608_CR34","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00401-019-02040-w","volume":"138","author":"N Van Den Berge","year":"2019","unstructured":"Van Den Berge N, Ferreira N, Gram H, Mikkelsen TW, Alstrup AKO, Casadei N, et al. Evidence for bidirectional and trans-synaptic parasympathetic and sympathetic propagation of alpha-synuclein in rats. Acta Neuropathol. 2019;138:535\u201350.","journal-title":"Acta Neuropathol."},{"key":"608_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-017-1777-8","volume":"135","author":"A Lionnet","year":"2018","unstructured":"Lionnet A, Leclair-Visonneau L, Neunlist M, Murayama S, Takao M, Adler CH, et al. Does Parkinson\u2019s disease start in the gut? Acta Neuropathol. 2018;135:1\u201312.","journal-title":"Acta Neuropathol."},{"key":"608_CR36","doi-asserted-by":"crossref","first-page":"e89327","DOI":"10.1371\/journal.pone.0089327","volume":"9","author":"K Taguchi","year":"2014","unstructured":"Taguchi K, Watanabe Y, Tsujimura A, Tatebe H, Miyata S, Tokuda T, et al. Differential expression of alpha-synuclein in hippocampal neurons. PLoS One. 2014;9:e89327.","journal-title":"PLoS One."},{"key":"608_CR37","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna E, Decker SC, Riddle DM, Caputo A, Zhang B, Cole T, et al. Differential \u03b1-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol. 2018;135:855\u201375.","journal-title":"Acta Neuropathol"},{"key":"608_CR38","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-017-1787-6","volume":"135","author":"D Erskine","year":"2018","unstructured":"Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, et al. Regional levels of physiological \u03b1-synuclein are directly associated with Lewy body pathology. Acta Neuropathol. 2018;135:153\u20134.","journal-title":"Acta Neuropathol."},{"key":"608_CR39","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.24960","volume":"81","author":"M Vassilaki","year":"2017","unstructured":"Vassilaki M, Christianson TJ, Mielke MM, Geda YE, Kremers WK, Machulda MM, et al. Neuroimaging biomarkers and impaired olfaction in cognitively normal individuals. Ann Neurol. 2017;81:871\u201382.","journal-title":"Ann Neurol."},{"key":"608_CR40","doi-asserted-by":"crossref","first-page":"e700","DOI":"10.1212\/WNL.0000000000006919","volume":"92","author":"CS Dintica","year":"2019","unstructured":"Dintica CS, Marseglia A, Rizzuto D, Wang R, Seubert J, Arfanakis K, et al. Impaired olfaction is associated with cognitive decline and neurodegeneration in the brain. Neurology. 2019;92:e700\u20139.","journal-title":"Neurology."},{"key":"608_CR41","doi-asserted-by":"crossref","first-page":"15410","DOI":"10.1523\/JNEUROSCI.1909-09.2009","volume":"29","author":"E Wattendorf","year":"2009","unstructured":"Wattendorf E, Welge-L\u00fcssen A, Fiedler K, Bilecen D, Wolfensberger M, Fuhr P, et al. Olfactory impairment predicts brain atrophy in Parkinson\u2019s disease. J Neurosci. 2009;29:15410\u20133.","journal-title":"J Neurosci."},{"key":"608_CR42","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/mds.25829","volume":"29","author":"EY Lee","year":"2014","unstructured":"Lee EY, Eslinger PJ, Du G, Kong L, Lewis MM, Huang X. Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson\u2019s disease. Olfactory-related cortical atrophy is associated with olfactory dysfunction in Parkinson\u2019s disease. Mov Disord. 2014;29:1205\u20138.","journal-title":"Mov Disord."},{"key":"608_CR43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.parkreldis.2017.05.005","volume":"41","author":"A Campabadal","year":"2017","unstructured":"Campabadal A, Uribe C, Segura B, Baggio HC, Abos A, Garcia-Diaz AI, et al. Brain correlates of progressive olfactory loss in Parkinson\u2019s disease. Parkinsonism Relat Disord. 2017;41:44\u201350.","journal-title":"Parkinsonism Relat Disord"},{"key":"608_CR44","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1093\/brain\/awv211","volume":"138","author":"E Mak","year":"2015","unstructured":"Mak E, Su L, Williams GB, Firbank MJ, Lawson RA, Yarnall AJ, et al. Baseline and longitudinal grey matter changes in newly diagnosed Parkinson\u2019s disease: ICICLE-PD study. Brain. 2015;138:2974\u201386.","journal-title":"Brain."},{"key":"608_CR45","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1093\/brain\/118.6.1447","volume":"118","author":"WP Gai","year":"1995","unstructured":"Gai WP, Blessing WW, Blumbergs PC. Ubiquitin-positive degenerating neurites in the brainstem in Parkinson\u2019s disease. Brain. 1995;118:1447\u201359.","journal-title":"Brain."},{"key":"608_CR46","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Evans JR, Goris A, Foltynie T, Ban M, Robbins TW, et al. The distinct cognitive syndromes of Parkinson\u2019s disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009;132:2958\u201369.","journal-title":"Brain."},{"key":"608_CR47","doi-asserted-by":"crossref","first-page":"338","DOI":"10.7326\/0003-4819-133-5-200009050-00009","volume":"133","author":"DS Goldstein","year":"2000","unstructured":"Goldstein DS, Holmes C, Li ST, Bruce S, Metman LV, Cannon RO. Cardiac sympathetic denervation in Parkinson disease. Ann Intern Med. 2000;133:338\u201347.","journal-title":"Ann Intern Med"},{"key":"608_CR48","first-page":"71","volume":"41","author":"H Takatsu","year":"2000","unstructured":"Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson\u2019s disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71\u20137.","journal-title":"J Nucl Med"},{"key":"608_CR49","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.biomaterials.2015.12.021","volume":"82","author":"M Concei\u00e7\u00e3o","year":"2016","unstructured":"Concei\u00e7\u00e3o M, Mendon\u00e7a L, N\u00f3brega C, Gomes C, Costa P, Hirai H, et al. Intravenous administration of brain-targeted stable nucleic acid lipid particles alleviates Machado-Joseph disease neurological phenotype. Biomaterials. 2016;82:124\u201337.","journal-title":"Biomaterials."},{"key":"608_CR50","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.cell.2014.07.001","volume":"158","author":"J Baleriola","year":"2014","unstructured":"Baleriola J, Walker CA, Jean YY, Crary JF, Troy CM, Nagy PL, et al. Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions. Cell. 2014;158:1159\u201372.","journal-title":"Cell."}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0608-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41380-019-0608-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T17:01:15Z","timestamp":1684602075000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-019-0608-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,22]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1038\/s41380-019-0608-9","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,22]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}